Skip to content
★ Sign in to follow
TK

Takashi Kei Kishimoto

Directeur Scientifique
Cartesian Therapeutics, Inc.
Total declarations
22
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (8 ops.)
€214k

Latest filing published 01 Jun 2023 for Cartesian Therapeutics, Inc..

Filing timeline

BuySale
Takashi Kei Kishimoto

Insider track record

Disclosed buys
0
Disclosed sells
8
Signal history

Takashi Kei Kishimoto: trading record in brief

Takashi Kei Kishimoto, listed as senior executive, appears in our data through filings on Cartesian Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 28 December 2016 to 31 May 2023, the count stands at 22 filings.

On the market, this insider has only sold: 8 sales, €214k in total. Besides market trades, the filings include 6 share grants and 4 option exercises. So far in 2023, the count stands at no purchases and 4 sales.

The latest filing, published on 1 June 2023, reports a transaction in Cartesian Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Takashi Kei Kishimoto

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total

22 of 18 declarations